L. V. Plotnikova, A. M. Polyanichko, M. O. Kobeleva, A. A. Nikekhin, M. V. Uspenskaya, A. V. Kayava, A. D. Garifullin, S. V. Voloshin, “Analysis of blood serum by the method of refractometry in antitumor therapy in patients with multiple myeloma”, Optics and Spectroscopy, 2018, Volume 124, Issue 1,Pages <nobr>140

This article is cited in 1 paper

Geometric and applied optics

Analysis of blood serum by the method of refractometry in antitumor therapy in patients with multiple myeloma

L. V. Plotnikova^a, A. M. Polyanichko^b, M. O. Kobeleva^a, A. A. Nikekhin^a, M. V. Uspenskaya^a, A. V. Kayava^acde, A. D. Garifullin^f, S. V. Voloshin^f

^a ITMO University, St. Petersburg, 197101, Russia
^b Saint Petersburg State University
^c Université Montpellier II, France
^d Centre de Recherche en Biologie cellulaire de Montpellier, France
^e Institut de Biologie Computationnelle (IBC), 34095 Montpellier, France
^f Russian Scientific Research Institute of Hematology and Transfusiology, St. Petersburg, 191024, Russia

Abstract: The serum of patients with multiple myeloma was examined by refractometric methods before and after the course of antitumor therapy. It was found that the amount of protein in the serum of patients with multiple myeloma, determined by the value of the serum refractive index, tended to decrease after the course of treatment. The value of the refractive index of blood serum can be used as an additional criterion for assessing the dynamics of changes in blood-serum properties during antitumor therapy.

Received: 02.08.2017

DOI: 10.21883/OS.2018.01.45369.173-17